antimicrobial resistance – Page 2

mGem: Sepsis and antimicrobial resistance in the context of advanced HIV disease

mycolabadmin

This review examines how serious infections (sepsis) from bacteria and fungi affect people with advanced HIV disease, particularly in hospitals. The infections have become more dangerous due to antimicrobial resistance, and many cases go undiagnosed because of limited laboratory capabilities. The paper calls for better diagnostic tools and treatment strategies tailored to resource-limited settings where most advanced HIV disease cases occur.

Antifungal effect of soil Bacillus bacteria on pathogenic species of the fungal genera Aspergillus and Trichophyton

mycolabadmin

Scientists found that certain bacteria naturally occurring in soil can effectively kill harmful fungi that cause infections in humans. By isolating and testing different Bacillus bacteria species, researchers discovered that some were even more effective at inhibiting fungal growth than commonly used antifungal medications. This finding suggests a promising natural alternative to combat fungal infections, especially as many fungi are becoming resistant to traditional antifungal drugs.

Enhancing antifungal stewardship: The educational and healthcare benefits of involving pharmacy students in audits

mycolabadmin

This study examined how pharmacy students could help improve the use of fluconazole, a common antifungal medication, in hospitals. Researchers found that nearly one-third of fluconazole prescriptions were not being used appropriately. By having pharmacy students participate in reviewing prescriptions under expert supervision, hospitals could better identify problems and educate future pharmacists, while the students gained valuable real-world experience in patient care.

Botrytis cinerea combines four molecular strategies to tolerate membrane-permeating plant compounds and to increase virulence

mycolabadmin

Botrytis cinerea is a fungus that causes plant disease by overcoming plant chemical defenses called saponins. Researchers discovered that this fungus uses four different molecular strategies to survive saponin exposure: it breaks down saponins with an enzyme, modifies membrane structures to resist saponin damage, activates proteins that protect the cell membrane, and repairs membrane damage after it occurs. These findings explain how this fungus successfully infects plants protected by saponins and reveal new understanding of how microorganisms resist antimicrobial compounds.

Bacterial and Fungal Pathogens in Chronic Suppurative Otitis Media and Otitis Externa With Persistent Otorrhea: A Cross-Sectional Study in a Low- to Middle-Income Country (Pakistan)

mycolabadmin

This study examined ear infections in Karachi, Pakistan, identifying which bacteria and fungi cause chronic ear drainage. Researchers found that Pseudomonas bacteria and Aspergillus fungi were the most common culprits, often appearing together. The warm, humid climate and poor sanitation in the area contribute to these infections, which need better diagnostic testing and tailored treatment approaches to improve patient outcomes.

In silico screening and molecular dynamics analysis of natural DHPS enzyme inhibitors targeting Acinetobacter baumannii

mycolabadmin

Researchers used computer modeling to find natural compounds from plants and mushrooms that can inhibit a key bacterial enzyme (DHPS) in dangerous antibiotic-resistant bacteria called Acinetobacter baumannii. They tested thousands of natural molecules and identified two promising candidates that bind strongly to this enzyme and prevent bacteria from producing folic acid, which they need to survive. The study suggests these natural compounds could potentially be developed into new antibiotics to fight infections caused by drug-resistant bacteria.

Introduction to XIV updating course of antimicrobials and infectious diseases

mycolabadmin

Healthcare professionals gathered at a major conference in Madrid to learn about the latest advances in treating infections caused by antibiotic-resistant bacteria and other pathogens. The course highlighted new antibiotic combinations that work against previously untreatable infections, faster ways to identify infections in emergency rooms and intensive care units, and modern treatment strategies based on scientific evidence. Speakers emphasized the importance of using antibiotics wisely, using personalized medicine approaches, and collaborating between laboratory scientists and clinicians to improve patient outcomes.

Ganoderma lucidum inspired silver nanoparticles and its biomedical applications with special reference to drug resistant Escherichia coli isolates from CAUTI

mycolabadmin

Researchers created tiny silver particles using a medicinal mushroom called Ganoderma lucidum to fight dangerous bacteria that resist antibiotics and are associated with urinary catheter infections. These nanoparticles were found to effectively kill drug-resistant bacteria, work as antioxidants better than a common antioxidant standard, and showed promise in killing breast cancer cells. This eco-friendly approach offers a natural alternative to conventional antibiotics for treating serious antibiotic-resistant infections.

Enhancing antifungal stewardship: The educational and healthcare benefits of involving pharmacy students in audits

mycolabadmin

Researchers studied how involving pharmacy students in reviewing fluconazole (an antifungal medication) prescriptions could help hospitals improve their antifungal medication use and provide valuable training. Out of 145 prescriptions audited, about two-thirds were appropriate while one-third had issues like unnecessary use or drug interactions. Both the students and hospitals benefited significantly, with students gaining practical clinical experience while hospitals identified prescribing problems that could be improved.

Biofilms and Chronic Wounds: Pathogenesis and Treatment Options

mycolabadmin

Chronic wounds, such as diabetic foot ulcers and burn injuries, are often complicated by bacterial and fungal biofilms—protective communities of microorganisms that resist antibiotics and delay healing. This review summarizes how biofilms form, why they are difficult to treat with standard approaches, and discusses new therapeutic strategies. While debridement and antiseptics remain important, combining them with novel treatments like bacteriophages, enzyme therapies, and nanotechnology offers better chances for healing these stubborn wounds.

Research Topic: antimicrobial resistance